The Electronic Trial Master File: So Much More than a Secure Document Repository

CONSHOHOCKEN, Pa., Sept. 11, 2013 /PRNewswire/ -- NextDocs, a leading provider of regulated content management and compliance solutions, and Microsoft will co-present in a Drug Information Association (DIA) webinar entitled, The Electronic Trial Master File: So Much More than a Secure Document Repository.

The 45-minute webinar will examine the implementation of an electronic Trial Master File (eTMF) solution and explore the business benefits gained from leveraging the rich data within the eTMF.

Gabor Fari, Director of Life Sciences Solutions at Microsoft, and Sharon Ames, Enterprise Program Director at NextDocs will present and discuss:

• Using eTMF data to define and measure Key Performance Indicators (KPIs) and operational metrics 
• Using interoperability and standards to streamline the clinical trial process
• Ensuring data availability through recommended and mandatory metadata 
• Obtaining quick and thorough query results 

The webinar will air on Tuesday, September 17, 2013 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) and will be available for replay thereafter. 

This complimentary webinar is open to all but requires registration at the DIA website.  To register, please visit the online instruction section of the "Meetings & Training" tab at www.dia.org or click here.

About NextDocs Corporation
NextDocs is the global leader in providing compliance solutions including quality management software, regulatory document management and clinical portals. NextDocs solutions enable businesses in regulated industries to achieve compliance with FDA and other regulations while automating processes, improving efficiency and dramatically reducing costs. NextDocs' customers include leading pharmaceutical companies, biotechs, medical device companies and CROs. For more information on NextDocs Corporation and its software solutions, visit www.nextdocs.com.

About DIA
DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health-care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C. and Latin America. Visit our website at www.diahome.org; follow DIA on Facebook, Twitter (#druginfoassn), LinkedIn, Flickr and YouTube.

Contact:
Dan Cahill
1-917-617-0106
[email protected]

SOURCE NextDocs Corporation